Fig. 4From: Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialKaplan–Meier plot of progression-free survival (PFS); the median progression-free survival (95% CI) for patients who received therapy was 0.26 years (0.19, 0.35)Back to article page